Condition: Langerhans Cell Histiocytosis · Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Treatment of Adult Patients with Newly Diagnosed Langerhans Cell Histiocytosis (LCH) Using a Low-Dose Cytarabine Combined with Thalidomide Regimen.
This description comes directly from the study's public registry record.
Xinxin XX Cao, doctor · +86-18618315968 · caoxinxin@126.com
Huilei HL Miao, doctor · +86-18801317695 · miaohl13@163.com
Always discuss trial participation with your own doctor first.
| Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College | Beijing, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07187193